Literature DB >> 7712594

Modulation of mitogenesis by liver fatty acid binding protein.

S Sorof1.   

Abstract

Liver fatty acid binding protein (L-FABP), a cytoplasmic 14 kDa protein previously termed Z protein, is conventionally considered to be an intracellular carrier of fatty acids in rat hepatocytes. The following evidence now indicates that L-FABP is also a specific mediator of mitogenesis of rat hepatocytes: a. the synergy between the action of L-FABP and unsaturated fatty acids, especially linoleic acid, in the promotion of cell proliferation; b. the specific requirement for L-FABP in induction of mitogenesis by two classes of nongenotoxic hepatocarcinogenic peroxisome proliferators (amphipathic carboxylates and tetrazole-substituted acetophenones); c. the direct correlation between the binding avidities of different prostaglandins for L-FABP and their relative growth inhibitory activities toward cultured rat hepatocytes; d. the temporal coincidences between the covalent binding to L-FABP by chemically reactive metabolites of the genotoxic carcinogens, 2-acetylaminofluorene and aminoazo dyes, and their growth inhibitions of hepatocytes during liver carcinogenesis in rats; e. and f. the marked elevations of L-FABP in rat liver during mitosis in normal and regenerating hepatocytes, and during the entire cell cycle in the hyperplastic and malignant hepatocytes that are produced by the genotoxic carcinogens, 2-acetylaminofluorene and aminoazo dyes. These actions of L-FABP are consistent with those of a protein involved in regulation of hepatocyte multiplication. Discovery that L-FABP, the target protein of the two types of genotoxic carcinogens, is required for the mitogenesis induced by two classes of nongenotoxic carcinogens points to a common process by which both groups of carcinogens promote hepatocyte multiplication. The implication is that during tumor promotion of liver carcinogenesis, these genotoxic and nongenotoxic carcinogens modify the normal process by which L-FABP, functioning as a specific receptor of unsaturated fatty acids or their metabolites, promotes the multiplication of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7712594     DOI: 10.1007/bf00666102

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  105 in total

Review 1.  Fatty acid binding proteins: recent concepts of regulation and function.

Authors:  R K Ockner; R M Kaikaus; N M Bass
Journal:  Prog Clin Biol Res       Date:  1992

Review 2.  Biological activities and mechanisms of action of PGJ2 and related compounds: an update.

Authors:  M Fukushima
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1992-09       Impact factor: 4.006

3.  Effects of chronic treatment with the leukotriene D4-antagonist compound LY171883 on B6C3F1 mice.

Authors:  A M Bendele; D M Hoover; R B van Lier; P S Foxworthy; P I Eacho
Journal:  Fundam Appl Toxicol       Date:  1990-11

Review 4.  Functions of fatty acid binding proteins.

Authors:  R M Kaikaus; N M Bass; R K Ockner
Journal:  Experientia       Date:  1990-06-15

Review 5.  Cell proliferation in carcinogenesis.

Authors:  S M Cohen; L B Ellwein
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

6.  Mitosis in hepatocytes is generally associated with elevated levels of the target polypeptide of a liver carcinogen.

Authors:  R P Custer; S Sorof
Journal:  Differentiation       Date:  1985       Impact factor: 3.880

7.  Normal liver chromatin contains a firmly bound and larger protein related to the principal cytosolic target polypeptide of a hepatic carcinogen.

Authors:  S A Vinores; J J Churey; J M Haller; S J Schnabel; R P Custer; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene.

Authors:  O Bardot; T C Aldridge; N Latruffe; S Green
Journal:  Biochem Biophys Res Commun       Date:  1993-04-15       Impact factor: 3.575

9.  Regulation of pathways of extramitochondrial fatty acid oxidation and liver fatty acid-binding protein by long-chain monocarboxylic fatty acids in hepatocytes. Effect of inhibition of carnitine palmitoyltransferase I.

Authors:  R M Kaikaus; Z Sui; N Lysenko; N Y Wu; P R Ortiz de Montellano; R K Ockner; N M Bass
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

10.  Glutathione-protein mixed disulfide decreases the affinity of rat liver fatty acid-binding protein for unsaturated fatty acid.

Authors:  M Hitomi; S Odani; T Ono
Journal:  Eur J Biochem       Date:  1990-02-14
View more
  14 in total

1.  Expression of liver fatty acid binding protein alters growth and differentiation of embryonic stem cells.

Authors:  F Schroeder; B P Atshaves; O Starodub; A L Boedeker; R R Smith; J B Roths; W B Foxworth; A B Kier
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

Review 2.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

3.  FABP1 knockdown in human enterocytes impairs proliferation and alters lipid metabolism.

Authors:  Luciana Rodriguez Sawicki; Natalia María Bottasso Arias; Natalia Scaglia; Lisandro Jorge Falomir Lockhart; Gisela Raquel Franchini; Judith Storch; Betina Córsico
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-09-13       Impact factor: 4.698

Review 4.  Acyl-CoA binding proteins: multiplicity and function.

Authors:  R E Gossett; A A Frolov; J B Roths; W D Behnke; A B Kier; F Schroeder
Journal:  Lipids       Date:  1996-09       Impact factor: 1.880

5.  Role of cytosolic liver fatty acid binding protein in hepatocellular oxidative stress: effect of dexamethasone and clofibrate treatment.

Authors:  G Rajaraman; G Q Wang; J Yan; P Jiang; Y Gong; F J Burczynski
Journal:  Mol Cell Biochem       Date:  2006-08-19       Impact factor: 3.396

6.  Membrane-associated and cytoplasmic fatty acid-binding proteins.

Authors:  F A Van Nieuwenhoven; G J Van der Vusse; J F Glatz
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

7.  Enhanced expression of cytosolic fatty acid binding protein and fatty acid uptake during liver regeneration in rats.

Authors:  GuQi Wang; Qing Ming Chen; Gerald Y Minuk; Yuewen Gong; Frank J Burczynski
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

8.  1H, 15N and 13C resonance assignments and secondary structure of apo liver fatty acid-binding protein.

Authors:  H Wang; Y He; K T Hsu; J F Magliocca; J Storch; R E Stark
Journal:  J Biomol NMR       Date:  1998-07       Impact factor: 2.835

Review 9.  Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.

Authors:  Jeffrey M Peters; Holly E Hollingshead; Frank J Gonzalez
Journal:  Clin Sci (Lond)       Date:  2008-08       Impact factor: 6.124

10.  Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein.

Authors:  Yun-Li Wu; Xian-E Peng; Yi-Bing Zhu; Xiao-Li Yan; Wan-Nan Chen; Xu Lin
Journal:  J Virol       Date:  2015-12-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.